{"id":3328,"date":"2019-10-17T13:20:55","date_gmt":"2019-10-17T13:20:55","guid":{"rendered":"http:\/\/www.enyopharma.com\/fr\/?p=3328"},"modified":"2019-10-17T13:20:55","modified_gmt":"2019-10-17T13:20:55","slug":"enyo-pharma-annonce-plusieurs-presentations-de-donnees-sur-eyp001-lors-de-la-conference-aasld","status":"publish","type":"post","link":"https:\/\/www.enyopharma.com\/fr\/enyo-pharma-annonce-plusieurs-presentations-de-donnees-sur-eyp001-lors-de-la-conference-aasld\/","title":{"rendered":"ENYO PHARMA ANNONCE PLUSIEURS PRESENTATIONS DE DONNEES SUR EYP001 LORS DE LA CONFERENCE AASLD"},"content":{"rendered":"<p>Lyon, France. 17 Octobre, 2019 &#8211; Â鶹Æƽâ°æ sera pr\u00e9sent \u00e0 l&#8217;AASLD \u00e0 Boston en Novembre prochain pour pr\u00e9senter quatre posterss et faire une pr\u00e9sentation orale sur son compos\u00e9 principal EYP001. ENYO organise en parall\u00e8le le 10 novembre un symposium pr\u00e9sent\u00e9 par des KOL qui pr\u00e9sentera les derni\u00e8res avanc\u00e9es scientifiques sur les avantages potentiels des agonistes de FXR pour le traitement du VHB.<\/p>\n <a href=\"http:\/\/www.enyopharma.com\/wp-content\/uploads\/2019\/10\/AASLD_PR-_FINAL_OK.pdf\" target=\"_blank\" rel=\"noopener\" target=\"_blank\" class=\"tano-file\"><span class=\"tano_download_icon\"><\/span><span class=\"tano_file_title\">T\u00e9l\u00e9charger le communiquer complet (PDF)<\/span><\/a> \n","protected":false},"excerpt":{"rendered":"<p>Lyon, France. 17 Octobre, 2019 &#8211; Â鶹Æƽâ°æ sera pr\u00e9sent \u00e0 l&#8217;AASLD \u00e0 Boston en Novembre prochain pour pr\u00e9senter quatre posterss et faire une pr\u00e9sentation orale sur son compos\u00e9 principal EYP001. ENYO organise en parall\u00e8le le 10 novembre un symposium pr\u00e9sent\u00e9 par des KOL qui pr\u00e9sentera les derni\u00e8res avanc\u00e9es scientifiques sur les avantages potentiels des agonistes de FXR pour le traitement du VHB.<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/www.enyopharma.com\/fr\/enyo-pharma-annonce-plusieurs-presentations-de-donnees-sur-eyp001-lors-de-la-conference-aasld\/\">Lire la suite&nbsp;&raquo;<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-3328","post","type-post","status-publish","format-standard","hentry","category-press-releases-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/www.enyopharma.com\/fr\/category\/press-releases-fr\/\" rel=\"category tag\">Press releases<\/a>","rttpg_excerpt":"Lyon, France. 17 Octobre, 2019 &#8211; Â鶹Æƽâ°æ sera pr\u00e9sent \u00e0 l&#8217;AASLD \u00e0 Boston en Novembre prochain pour pr\u00e9senter quatre posterss et faire une pr\u00e9sentation orale sur son compos\u00e9 principal EYP001. ENYO organise en parall\u00e8le le 10 novembre un symposium pr\u00e9sent\u00e9 par des KOL qui pr\u00e9sentera les derni\u00e8res avanc\u00e9es scientifiques sur les avantages potentiels des&hellip;","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=3328"}],"version-history":[{"count":4,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3328\/revisions"}],"predecessor-version":[{"id":3493,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3328\/revisions\/3493"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=3328"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=3328"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=3328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}